Vantage Consulting Group’s CME Group CME Stock Holding History

Vantage Consulting Group’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-121	Closed	-$22K	–	394
2020 Q4	$22K	Buy	+121	New	+$20.6K	﹤0.01%	830

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vantage Consulting Group's CME Position: Q1 2021 in Review

Vantage Consulting Group sold out of CME Group (CME) in Q1 2021, closing a stake of 121 shares — an estimated $22K sold.

Vantage Consulting Group first reported a position in CME in Q4 2020 and held it in 1 quarter. The position peaked at $22K in Q4 2020. 1,062 funds tracked by Wall St. Rank hold CME as of Q1 2021.

Vantage Consulting Group reported no remaining CME Group position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 121 CME Group shares in Q1 2021, an estimated $22K.
Vantage Consulting Group first reported a position in CME Group in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's CME Group position peaked at $22K in Q4 2020.
1,062 funds tracked by Wall St. Rank held CME Group as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.